Cabeza Montilla, Laura Author
Evaluation of poly (lactic-co-glycolic acid) nanoparticles to improve the therapeutic efficacy of paclitaxel in breast cancer
- Laura Cabeza
- Mazen M. El-Hammadi
- Raul Ortiz
- Maria D. Cayero-Otero
- Julia Jiménez-López
- Gloria Perazzoli
- Lucia Martin-Banderas
- Jose M. Baeyens
- Consolación Melguizo
- Jose Prados
BioImpacts - 15/01/2022
- JCR Impact Factor: 2.6 (2022)
- CiteScore: 6.1 (2021)
- SJR: 0.682 (2021
- SNIP: 0.863 (2021
- JCR 5-year Impact Factor: 3.6
- JCR Categories: PHARMACOLOGY & PHARMACY
- Scopus
- ORCID
- Web of Science
The antitumor activity of sodium selenite alone and in combination with gemcitabine in pancreatic cancer: An in vitro and in vivo study
- Doello K.
- Mesas C.
- Quiñonero F.
- Perazzoli G.
- Cabeza L.
- Prados J.
- Melguizo C.
- Ortiz R.
Cancers - 1/7/2021
- JCR Quartile: Q1 (2021)
- JCR Impact Factor: 6.575 (2022)
- Category normalized Impact: 0.828 (2021)
- JCR 5-year Impact Factor: 6.886
- JCR Categories: ONCOLOGY
- Scopus
- ORCID
- Web of Science
Paclitaxel antitumor effect improvement in lung cancer and prevention of the painful neuropathy using large pegylated cationic liposomes
- Jiménez-López J.
- Bravo-Caparrós I.
- Cabeza L.
- Nieto F.R.
- Ortiz R.
- Perazzoli G.
- Fernández-Segura E.
- Cañizares F.J.
- Baeyens J.M.
- Melguizo C.
- Prados J.
BIOMEDICINE and PHARMACOTHERAPY - 1/1/2021
- JCR Impact Factor: 7.419 (2021)
- CiteScore: 9.3 (2020)
- SJR: 1.323 (2020
- SNIP: 1.443 (2020
- JCR 5-year Impact Factor: 6.581
- JCR Categories: MEDICINE, RESEARCH & EXPERIMENTAL
- Scopus
- ORCID
- Web of Science
Temozolomide: An Updated Overview of Resistance Mechanisms, Nanotechnology Advances and Clinical Applications
- Ortiz R.
- Perazzoli G.
- Cabeza L.
- Jiménez-Luna C.
- Luque R.
- Prados J.
- Melguizo C.
Current Neuropharmacology - 1/1/2021
10.2174/1570159x18666200626204005
- JCR Quartile: Q1 (2021)
- JCR Impact Factor: 7.708 (2022)
- Category normalized Impact: 2.561 (2021)
- CiteScore: 10.5 (2020)
- SJR: 1.955 (2020
- SNIP: 1.851 (2020
- JCR 5-year Impact Factor: 9.589
- JCR Categories: NEUROSCIENCES
- Scopus
- ORCID
- Web of Science
Nanomedicine to Overcome Multidrug Resistance Mechanisms in Colon and Pancreatic Cancer: Recent Progress
- Raúl Ortíz
- Francisco Quiñonero
- Beatriz García-Pinel
- Marco Fuel Herrera
- Cristina Mesas
- Laura Cabeza
- Consolación Melguizo Alonso
- Jose Prados
Cancers - 1/04/2021
- JCR Impact Factor: 6.575 (2021)
- JCR 5-year Impact Factor: 6.886
- JCR Categories: ONCOLOGY
- Scopus
- ORCID
- Web of Science
Antitumor Effect of the Ethanolic Extract from Seeds of Euphorbia lathyris in Colorectal Cancer
- Cristina Mesas
- Rosario Martínez
- Raúl Ortíz
- Milagros Galisteo
- María López-Jurado
- Laura Cabeza
- Gloria Perazzoli
- Consolación Melguizo Alonso
- Jesus Maria Porres Foulquie
- Jose Prados
Nutrients - 9/02/2021
- JCR Impact Factor: 6.706 (2021)
- JCR 5-year Impact Factor: 7.185
- JCR Categories: NUTRITION & DIETETICS
- Scopus
- ORCID
- Web of Science
Anemonia sulcata and Its Symbiont Symbiodinium as a Source of Anti-Tumor and Anti-Oxidant Compounds for Colon Cancer Therapy: A Preliminary In Vitro Study
- Laura Cabeza
- Mercedes Peña-Contreras
- Rosario Martínez
- Cristina Mesas
- Milagros Galisteo
- Gloria Perazzoli
- Jose Prados
- Jesus Maria Porres Foulquie
- Consolación Melguizo Alonso
Biology - 8/02/2021
- Scopus
- ORCID
- Web of Science
Nanoparticles in Colorectal Cancer Therapy: Latest In Vivo Assays, Clinical Trials, and Patents
- Cabeza L.
- Perazzoli G.
- Mesas C.
- Jiménez-Luna C.
- Prados J.
- Rama A.R.
- Melguizo C.
AAPS PHARMSCITECH - 1/7/2020
- JCR Impact Factor: 3.246 (2020)
- JCR 5-year Impact Factor: 3.473
- JCR Categories: PHARMACOLOGY & PHARMACY
Biomimetic magnetoliposomes as oxaliplatin nanocarriers: In vitro study for potential application in colon cancer
- Garcia-Pinel B.
- Jabalera Y.
- Ortiz R.
- Cabeza L.
- Jimenez-Lopez C.
- Melguizo C.
- Prados J.
Pharmaceutics - 1/6/2020
- JCR Impact Factor: 6.321 (2020)
- JCR 5-year Impact Factor: 6.734
- JCR Categories: PHARMACOLOGY & PHARMACY
- Scopus
- ORCID
- Web of Science
Bengamide Analogues Show A Potent Antitumor Activity against Colon Cancer Cells: A Preliminary Study
- García-Pinel B.
- Porras-Alcalá C.
- Cabeza L.
- Ortiz R.
- Prados J.
- Melguizo C.
- Cheng-Sánchez I.
- López-Romero J.M.
- Sarabia F.
Marine Drugs - 2/5/2020
- JCR Impact Factor: 5.118 (2020)
- JCR 5-year Impact Factor: 5.951
- JCR Categories: CHEMISTRY, MEDICINAL
- Scopus
- ORCID
- Web of Science
Combinaciones terapéuticas y sus ventajas en el tratamiento del síndrome de dolor miofascial
- Laura Cabeza
- Gloria Perazzoli
- Ester Calzado Bon
Acercamiento multidisciplinar a la salud: Volumen IV - 2019
- Dialnet
Efectos del trabajo a turnos en enfermeras del servicio de urgencias hospitalarias entre 55 y 65 años en las etapas menopausia y post-menopausia
- Laura Cabeza
- Gloria Perazzoli
- Ester Calzado Bon
Investigación en salud y envejecimiento: Volumen VI - 2019
- Dialnet
Mejora de la actividad antitumoral de agentes citotóxicos mediante el uso de nanoplataformas poliméricas: aplicación en cáncer de colon, mama y pulmón
- Laura Cabeza
- Consolación Melguizo
- José Carlos Prados Salazar
- Raul Ortiz Quesada
2017
- Dialnet
This author has no conferences.
This author has no patents.
Nanomedicine and Hyperthermia for the Treatment of Gastrointestinal Cancer: A Systematic Review
- Lidia Gago
- Francisco Quiñonero
- Gloria Perazzoli
- Consolacion Melguizo
- Jose Prados
- Raul Ortiz
- Laura Cabeza
Pharmaceutics - 13/06/2023
- Scopus
- ORCID
- Web of Science
Correction: Specific driving of the suicide E gene by the CEA promoter enhances the effects of paclitaxel in lung cancer (Cancer Gene Therapy, (2019), 10.1038/s41417-019-0137-3)
- Ballesteros A.
- Hernández R.
- Perazzoli G.
- Cabeza L.
- Melguizo C.
- Vélez C.
- Prados J.
CANCER GENE THERAPY - 1/1/2020
- JCR Impact Factor: 5.987 (2020)
- CiteScore: 8.1 (2020)
- SJR: 1.535 (2020
- SNIP: 1.113 (2020
- JCR 5-year Impact Factor: 5.358
- JCR Categories: MEDICINE, RESEARCH & EXPERIMENTAL
h index
Scopus: 13
Web of Science: 21
i10 index
Scopus: 18
Web of Science: 30
Author profiles
-
ORCID
-
Web of Science ResearcherID
-
Scopus Author ID
-
Dialnet id
Research projects at UAL
-
Acronym CV20-78799Since: September 8, 2020Until: September 7, 2021Funded by: JUNTAFunding / grant amount: 60,000.00 EURRole: Investigador